The transition from NAFLD to MAFLD: One size still does not fit all-Time for a tailored approach?
- PMID: 35503710
- DOI: 10.1002/hep.32552
The transition from NAFLD to MAFLD: One size still does not fit all-Time for a tailored approach?
Comment on
-
Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?Hepatology. 2022 Nov;76(5):1423-1437. doi: 10.1002/hep.32499. Epub 2022 May 2. Hepatology. 2022. PMID: 35363908
References
REFERENCES
-
- Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202-9.
-
- Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-57.
-
- Younossi ZM, Paik JM, Al Shabeeb R, Golabi P, Younossi I, Henry L. Are there outcome differences between NAFLD and metabolic-associated fatty liver disease? Hepatology. 2022;76:1423-37.
-
- Ayada I, Kleef LA, Alferink LJM, Li P, Knegt RJ, Pan Q, et al. Systematically comparing epidemiological and clinical features of MAFLD and NAFLD by meta-analysis: focusing on the non-overlap groups. Liver Int. 2022;42(2):277-87.
-
- Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology. 2017;65(5):1557-65.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
